Literature DB >> 7855192

Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.

A J Kennedy1, E L Gibson, M T O'Connell, G Curzon.   

Abstract

The effects of pretreatments on behavioural responses to activation of 5-HT1C receptors by m-chlorophenylpiperazine (mCPP) were investigated. The hypo locomotor and anxiogenic effects of mCPP (social interaction test) were influenced neither by previous housing (single versus grouped) nor by restraint (2 h, 24 h previously). In the absence of mCPP, 24 h group housing led to decreased social interaction and the restraint procedure led to significant decreases of feeding and locomotion. The hypophagic effect of mCPP was unaffected by previous restraint. However, chronic pretreatment with mCPP (2.5 mg/kg per day IP x 14) or with the antidepressant 5-HT reuptake inhibitor sertraline (5 mg/kg per day SC x 14) attenuated all three behaviours. The above findings are discussed with respect to published data on effects of pretreatments on responses to the activation of 5-HT1C receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7855192     DOI: 10.1007/bf02245708

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Long-term administration of m-chlorophenylpiperazine to rats does not alter functional sensitivity of either pre-synaptic or postsynaptic 5-HT1A receptors.

Authors:  C S Aulakh; J L Hill; T J Tolliver; D Marcantonio; D L Murphy
Journal:  J Psychopharmacol       Date:  1991-01       Impact factor: 4.153

Review 2.  Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms.

Authors:  B L Roth; M Hamblin; R D Ciaranello
Journal:  Neuropsychopharmacology       Date:  1990 Oct-Dec       Impact factor: 7.853

Review 3.  Adaptive regulation of central serotonin receptors linked to phosphoinositide hydrolysis.

Authors:  E Sanders-Bush
Journal:  Neuropsychopharmacology       Date:  1990 Oct-Dec       Impact factor: 7.853

Review 4.  Clinical experience with serotonin reuptake inhibiting antidepressants.

Authors:  J Mendels
Journal:  J Clin Psychiatry       Date:  1987-03       Impact factor: 4.384

5.  Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.

Authors:  E Hollander; C DeCaria; R Gully; A Nitescu; R F Suckow; J M Gorman; D F Klein; M R Liebowitz
Journal:  Psychiatry Res       Date:  1991-01       Impact factor: 3.222

6.  Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system.

Authors:  E Sanders-Bush; M Breeding; K Knoth; M Tsutsumi
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.

Authors:  G A Kennett
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.

Authors:  U Freo; H W Holloway; N H Greig; T T Soncrant
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.

Authors:  H H Berendsen; C L Broekkamp
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more
  6 in total

1.  Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.

Authors:  S P Vickers; K R Benwell; R H Porter; M J Bickerdike; G A Kennett; C T Dourish
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.

Authors:  J Benjamin; B D Greenberg; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

3.  Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.

Authors:  Diána Kostyalik; Zita Kátai; Szilvia Vas; Dorottya Pap; Péter Petschner; Eszter Molnár; István Gyertyán; Lajos Kalmár; László Tóthfalusi; Gyorgy Bagdy
Journal:  Exp Brain Res       Date:  2014-01-07       Impact factor: 1.972

4.  Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area.

Authors:  S Prisco; E Esposito
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test.

Authors:  André Rex; Jörg-Peter Voigt; Christina Gustedt; Simon Beckett; Heidrun Fink
Journal:  Psychopharmacology (Berl)       Date:  2004-05-28       Impact factor: 4.530

6.  Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.

Authors:  Sharon Rosenzweig-Lipson; Annmarie Sabb; Gary Stack; Paul Mitchell; Irwin Lucki; Jessica E Malberg; Steve Grauer; Julie Brennan; John F Cryan; Stacey J Sukoff Rizzo; John Dunlop; James E Barrett; Karen L Marquis
Journal:  Psychopharmacology (Berl)       Date:  2007-02-13       Impact factor: 4.415

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.